(3R)-6-[[4-[3-(cyclopentylamino)phenyl]pyrimidin-2-yl]amino]-1,3-dimethyl-4-propan-2-yl-3H-quinoxalin-2-one
C28H34N6O — CID 160873916
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-6-[[4-[3-(cyclopentylamino)phenyl]pyrimidin-2-yl]amino]-1,3-dimethyl-4-propan-2-yl-3H-quinoxalin-2-one
(3R)-6-[[4-[3-(cyclopentylamino)phenyl]pyrimidin-2-yl]amino]-1,3-dimethyl-4-propan-2-yl-3H-quinoxalin-2-one (PubChem CID 160873916) has the molecular formula C28H34N6O and a molecular weight of 470.62 g/mol. Its IUPAC name is (3R)-6-[[4-[3-(cyclopentylamino)phenyl]pyrimidin-2-yl]amino]-1,3-dimethyl-4-propan-2-yl-3H-quinoxalin-2-one.
Molecular Properties
| Compound Name | (3R)-6-[[4-[3-(cyclopentylamino)phenyl]pyrimidin-2-yl]amino]-1,3-dimethyl-4-propan-2-yl-3H-quinoxalin-2-one |
|---|---|
| PubChem CID | 160873916 |
| Molecular Formula | C28H34N6O |
| Molecular Weight | 470.62 g/mol |
| Exact Mass | 470.28 |
| IUPAC Name | (3R)-6-[[4-[3-(cyclopentylamino)phenyl]pyrimidin-2-yl]amino]-1,3-dimethyl-4-propan-2-yl-3H-quinoxalin-2-one |
| SMILES | CC(C)N1c2cc(Nc3nccc(-c4cccc(NC5CCCC5)c4)n3)ccc2N(C)C(=O)[C@H]1C |
| InChI | InChI=1S/C28H34N6O/c1-18(2)34-19(3)27(35)33(4)25-13-12-23(17-26(25)34)31-28-29-15-14-24(32-28)20-8-7-11-22(16-20)30-21-9-5-6-10-21/h7-8,11-19,21,30H,5-6,9-10H2,1-4H3,(H,29,31,32)/t19-/m1/s1 |
| InChIKey | SMCZUPOUEWETFN-LJQANCHMSA-N |
| XLogP | 5.82 |
| TPSA | 73.39 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 470.62 |
| LogP ≤ 5 | 5.82 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160873916 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.